Results 241 to 250 of about 114,630 (300)
There is a paucity of data regarding the effects of prenatal disease‐modifying therapies (DMTs) for multiple sclerosis (MS), on congenital anomalies in the offspring. Moreover, data on the association with neurodevelopmental disorders are lacking. This is an historical cohort study, within the Israeli Clalit Health Services database (2005–2024) that ...
Bar Rosh +4 more
wiley +1 more source
Glial cells in dementia: From cellular dysfunction to therapeutic frontiers. [PDF]
Jubair H.
europepmc +1 more source
Aberrant Splicing Signatures Underpin Oligodendrocyte Damage in ALS and Neuron Loss in FTD. [PDF]
Du C +6 more
europepmc +1 more source
Neuroglial Function and Hormonal Modulation in Neurodegenerative Diseases: The Influence of Sex Hormones. [PDF]
Alhajeri MM +10 more
europepmc +1 more source
Regional heterogeneities of oligodendrocytes underlie biased Ranvier node spacing along single axons in sound localization circuit. [PDF]
Egawa R +4 more
europepmc +1 more source
Integrated stress response inhibition prolongs the lifespan of a Pelizaeus-Merzbacher disease mouse model by increasing oligodendrocyte survival. [PDF]
Chen Y +15 more
europepmc +1 more source
Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases. [PDF]
Bogus K +4 more
europepmc +1 more source

